Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

A new model using mice with human hair follicles helps better understand hair loss from chemotherapy.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Dermatologists should carefully manage hair loss in cancer patients to improve their quality of life.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Wigs significantly improve the well-being of people with severe hair loss.

Minoxidil may help with hair loss caused by cancer treatments.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Hair loss can cause serious mental health problems and treating it requires a team of experts.